ロード中...
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
There is currently a lack of biological tools to study the replication cycle and pathogenesis of SARS-CoV-2, the etiological agent of COVID-19. Repurposing the existing tools, including antibodies of SARS-CoV, is an effective way to accelerate the development of therapeutics for COVID-19. Here, we e...
保存先:
| 出版年: | bioRxiv |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cold Spring Harbor Laboratory
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7402058/ https://ncbi.nlm.nih.gov/pubmed/32766589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.30.229377 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|